Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Solu Therapeutics logo — Solu Therapeutics is a next-generation therapeutics focused...

Solu Therapeutics

Solu Therapeutics is a next-generation therapeutics focused company working to eliminate cells that drive diseases.

Founded 2022 United States Boston, United States 23 employees Series A Total: $72.00M Biotechnology, Health and Wellness

General Information

Company Name Solu Therapeutics
Founded Year 2022
Location United States Boston, United States
Founders / Decision Makers
Team member
Employees 23
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Business Model Platform, B2B
Social

BounceWatch is an independent company data service, not affiliated with Solu Therapeutics. To contact Solu Therapeutics, visit solutherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Solu Therapeutics compare?

A PDF of Solu Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Solu Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Regulatory Approval Oct 08, 2026

Solu Therapeutics has initiated dosing for STX-0712 in the acute myeloid leukemia (AML) cohort of its Phase 1 study.

Solu Therapeutics a competitor of yours? Have our desk watch it

About Solu Therapeutics

Solu Therapeutics, founded in 2022, is carving a niche in the Biotechnology and Health and Wellness sectors. Headquartered in the United States, the company asserts its mission with the slogan: "Solu Therapeutics is a next-generation therapeutics focused company working to eliminate cells that drive diseases."

As a precision-medicine entity, Solu Therapeutics is committed to developing groundbreaking therapeutics targeting cells central to oncologic, inflammatory, and autoimmune diseases. This innovative focus offers significant potential in addressing complex health issues that are currently underserved.

Recently, the company secured a $31.00M Seed Round investment on 01 August 2023, indicative of strong confidence by prominent investors such as Longwood Fund, Santé Ventures, Alexandria Venture Investments, Astellas Venture Management, and DCVC Bio. This financial backing positions Solu Therapeutics well for future advancements and scaling.

Business keywords: next-generation therapeutics, precision medicine, oncologic diseases, inflammatory diseases, autoimmune diseases, disease-driving cell elimination, therapeutic development, cell therapy, innovative medicine, disease-focused treatments, targeted therapeutics

Services & Products

Development of novel therapeutic modalities
Design and engineering of antibody therapeutics
Discovery and preclinical evaluation of bifunctional molecules
Clinical trial advancement and support
Collaboration and partnership opportunities in drug development

Target Customers

Pharmaceutical and biotechnology companies Healthcare providers Patients in need of oncological and immunological therapies Research institutions interested in novel therapeutic approaches Investors looking for innovative biopharmaceutical technologies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $41.00M 10
Longwood Fund Santé Ventures Pappas Capital
Longwood Fund, Santé Ventures +8
01 Apr 2025
Seed $31.00M 5
Longwood Fund Santé Ventures Alexandria Venture Investments
Longwood Fund, Santé Ventures +3
01 Aug 2023

Solu Therapeutics Alternatives & Competitors

View All Alternatives
Solu Therapeutics vs
Xencor
Xencor United States

Proteins by Design

Post-IPO Equity
303 employees
Biotechnology, Health Care
Solu Therapeutics vs
Q32 Bio Inc.
Q32 Bio Inc. United States

Revolutionizing the future of targeted immune therapeutics

28 employees
Biotechnology, Health Care
Solu Therapeutics vs
Certa Therapeutics
Certa Therapeutics

Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases

Grant
10 employees
Biotechnology, Health and Wellness
Compare Solu Therapeutics vs Certa Therapeutics
View all alternatives

FAQ About Solu Therapeutics

Solu Therapeutics is a next-generation therapeutics focused company working to eliminate cells that drive diseases.
Solu Therapeutics was founded in 2022.
Solu Therapeutics is headquartered in Boston, United States.
Solu Therapeutics operates in Biotechnology and Health and Wellness. Its work centres on next-generation therapeutics, precision medicine, oncologic diseases and inflammatory diseases. Its customers include Pharmaceutical and biotechnology companies, Healthcare providers and Patients in need of oncological and immunological therapies.
Solu Therapeutics has a Platform and B2B business model.
Solu Therapeutics has approximately 23 employees.
Solu Therapeutics has completed 2 funding rounds, raising a total of $72.00M. The latest funding stage is Series A.
Solu Therapeutics offers: Development of novel therapeutic modalities, Design and engineering of antibody therapeutics, Discovery and preclinical evaluation of bifunctional molecules, Clinical trial advancement and support, Collaboration and partnership opportunities in drug development.
Top alternatives and competitors to Solu Therapeutics include Xencor, Q32 Bio Inc., Certa Therapeutics, Promedior, Immunic Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Solu Therapeutics and Xencor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Solu Therapeutics, https://bouncewatch.com/company/solu-therapeutics, updated 30 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout